365 related articles for article (PubMed ID: 27237757)
1. Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W
Mult Scler Relat Disord; 2016 May; 7():53-7. PubMed ID: 27237757
[TBL] [Abstract][Full Text] [Related]
2. [A case of neuromyelitis optica spectrum disorder developing a fulminant course with multiple white-matter lesions following fingolimod treatment].
Izaki S; Narukawa S; Kubota A; Mitsui T; Fukaura H; Nomura K
Rinsho Shinkeigaku; 2013; 53(7):513-7. PubMed ID: 23892961
[TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder.
Lin W; Chou CH; Yang FC; Tsai CK; Lin YK; Sung YF
Front Immunol; 2023; 14():1115120. PubMed ID: 37122715
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
Yan Y; Li Y; Fu Y; Yang L; Su L; Shi K; Li M; Liu Q; Borazanci A; Liu Y; He Y; Bennett JL; Vollmer TL; Shi FD
Sci China Life Sci; 2016 Dec; 59(12):1270-1281. PubMed ID: 26920678
[TBL] [Abstract][Full Text] [Related]
7. Brain and cord imaging features in neuromyelitis optica spectrum disorders.
Cacciaguerra L; Meani A; Mesaros S; Radaelli M; Palace J; Dujmovic-Basuroski I; Pagani E; Martinelli V; Matthews L; Drulovic J; Leite MI; Comi G; Filippi M; Rocca MA
Ann Neurol; 2019 Mar; 85(3):371-384. PubMed ID: 30635936
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord atrophy in neuromyelitis optica spectrum disorders.
Wang Y; Wang Y; Tan S; Lu Z
Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis.
Kim SH; Hyun JW; Joung A; Lee SH; Kim HJ
PLoS One; 2016; 11(12):e0167783. PubMed ID: 27936193
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Ayzenberg I; Schöllhammer J; Hoepner R; Hellwig K; Ringelstein M; Aktas O; Kümpfel T; Krumbholz M; Trebst C; Paul F; Pache F; Obermann M; Zeltner L; Schwab M; Berthele A; Jarius S; Kleiter I;
J Neurol; 2016 Mar; 263(3):575-82. PubMed ID: 26810718
[TBL] [Abstract][Full Text] [Related]
11. Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings.
Sechi E; Addis A; Batzu L; Mariotto S; Ferrari S; Conti M; Sechi G
Mult Scler; 2018 Apr; 24(5):685-688. PubMed ID: 28814166
[TBL] [Abstract][Full Text] [Related]
12. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
13. Eleven episodes of recurrent optic neuritis of the same eye for 22 years eventually diagnosed as neuromyelitis optica spectrum disorder.
Yew YC; Hor JY; Lim TT; Kanesalingam R; Ching YM; Arip M; Easaw PE; Eow GB
Mult Scler Relat Disord; 2016 Nov; 10():22-25. PubMed ID: 27919493
[TBL] [Abstract][Full Text] [Related]
14. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
[TBL] [Abstract][Full Text] [Related]
15. Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.
Ayrignac X; Dalière CC; Nerrant E; Vincent T; De Seze J; Labauge P
Mult Scler; 2014 Sep; 20(10):1401-3. PubMed ID: 24852925
[TBL] [Abstract][Full Text] [Related]
16. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
17. Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.
Min JH; Kim BJ; Lee KH
Mult Scler; 2012 Jan; 18(1):113-5. PubMed ID: 22146605
[TBL] [Abstract][Full Text] [Related]
18. A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.
Sawada J; Orimoto R; Misu T; Katayama T; Aizawa H; Asanome A; Takahashi K; Saito T; Anei R; Kamada K; Miyokawa N; Takahashi T; Fujihara K; Hasebe N
Mult Scler; 2014 Sep; 20(10):1413-6. PubMed ID: 24986696
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
20. [Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Hervás-García JV; Grau-López L; Doménech-Puigcerver S; Ramo-Tello C
Rev Neurol; 2014 Jan; 58(1):20-4. PubMed ID: 24343537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
